Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.32 $204,135 - $345,781
-104,151 Reduced 49.55%
106,049 $218,000
Q2 2022

Aug 15, 2022

BUY
$2.27 - $4.86 $72,186 - $154,548
31,800 Added 17.83%
210,200 $582,000
Q1 2022

May 13, 2022

SELL
$3.69 - $5.65 $81,180 - $124,300
-22,000 Reduced 10.98%
178,400 $780,000
Q3 2021

Nov 12, 2021

BUY
$5.54 - $7.51 $59,278 - $80,357
10,700 Added 5.64%
200,400 $1.24 Million
Q2 2021

Aug 12, 2021

BUY
$7.78 - $11.4 $322,092 - $471,960
41,400 Added 27.92%
189,700 $1.61 Million
Q1 2021

May 17, 2021

SELL
$5.12 - $8.48 $29,184 - $48,336
-5,700 Reduced 3.7%
148,300 $1.17 Million
Q4 2020

Feb 03, 2021

SELL
$3.16 - $7.03 $109,336 - $243,238
-34,600 Reduced 18.35%
154,000 $896,000
Q3 2020

Nov 16, 2020

BUY
$3.26 - $4.73 $614,836 - $892,078
188,600 New
188,600 $639,000
Q1 2020

May 06, 2020

SELL
$1.44 - $3.02 $131,472 - $275,726
-91,300 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$2.67 - $3.65 $243,771 - $333,245
91,300 New
91,300 $268,000

Others Institutions Holding AFMD

About Affimed N.V.


  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $185M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.